CAH logo Cardinal Health +
Cardinal Health
+

Cardinal Health (CAH) Business News

Track Cardinal Health in real time with a live news feed covering Cardinal Health stock news, official press releases, company announcements, and an archive of historical Cardinal Health news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection

Cardinal Health Board of Directors Approves Quarterly Dividend

PRNewsWire

4:40 PM | Tuesday | May 5, 2026

news photo
Loading...

DUBLIN, Ohio, May 5, 2026  /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved an increase to its quarterly dividend to $0.5158 per share, out of the Company's capital surplus. The dividend will be payable on July 15, 2026 to shareholders of record at the close of business on July 1, 2026.

Read full article redirect
4:40 PM | Tuesday | May 5, 2026

Cardinal Health Board of Directors Approves Quarterly Dividend

PRNewsWire

DUBLIN, Ohio, May 5, 2026  /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved an increase to its quarterly dividend to $0.5158 per share, out of the Company's capital surplus. The dividend will be payable on July 15, 2026 to shareholders of record at the close of business on July 1, 2026.

Read full article arrow
News Thumbnail
6:45 AM | Thursday | Apr 30, 2026

Cardinal Health Reports Third Quarter Fiscal Year 2026 Results and Raises Outlook

PRNewsWire

Revenue increased 11% to $60.9 billion GAAP 1 operating earnings decreased 30% to $509 million; GAAP diluted EPS decreased 20% to $1.69 Non-GAAP operating earnings increased 18% to $956 million; non-GAAP diluted EPS increased 35% to $3.17 Cardinal Health raises and narrows fiscal year 2026 non-GAAP EPS guidance2 to $10.70 to $10.
80 Cardinal Health reduces debt and completes additional $250 million share repurchase, bringing FY26 repurchase total to $1.0 billion DUBLIN, Ohio, April 30, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported third quarter fiscal year 2026 revenues of $60.9 billion, an increase of 11% from the third quarter of fiscal year 2025. Third quarter GAAP operating earnings decreased 30% to $509 million and GAAP diluted earnings per share (EPS) decreased 20% to $1.69, reflecting a $184 million pre-tax... Read more

Read full article arrow
News Thumbnail
7:00 AM | Tuesday | Apr 14, 2026

Cardinal Health report highlights growing momentum to expand advanced therapies into community care settings

PRNewsWire

Research confirms advanced therapies are moving beyond inpatient hospitals, with providers increasingly supporting partnerships that bring life-changing treatments closer to patients' homes. DUBLIN, Ohio, April 14, 2026 /PRNewswire/ -- Today, Cardinal Health (NYSE: CAH) released its 2026 Advanced Therapies Report: Perspectives on Community Expansion, offering new insights into how the expanding advanced therapy pipeline is reshaping sites of care.

Read full article arrow
News Thumbnail
7:00 AM | Wednesday | Apr 1, 2026

Cardinal Health expands Actinium-225 production capacity to support growing demand for novel cancer therapies

PRNewsWire

DUBLIN, Ohio, April 1, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) today announced a significant expansion of its Actinium-225 (Ac-225) production capabilities at the company's Center for Theranostics Advancement (CTA) in Indianapolis, Indiana. The addition of a high-capacity production line to its Drug Master File (DMF) will substantially increase Cardinal Health's supply of cGMP-compliant Ac-225 for use in investigational therapeutic drug products and future commercial manufacturing novel therapies.

Read full article arrow
News Thumbnail
6:45 AM | Tuesday | Mar 24, 2026

Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2026 on April 30

PRNewsWire

DUBLIN, Ohio, March 24, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2026 on April 30 as previously indicated, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m.

Read full article arrow
News Thumbnail
6:45 AM | Monday | Mar 23, 2026

Cardinal Health Appoints Patricia A. Hemingway Hall as Board Chair

PRNewsWire

DUBLIN, Ohio, March 23, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that its Board of Directors has appointed Patricia A. Hemingway Hall to succeed Gregory B.

Read full article arrow
News Thumbnail
7:00 AM | Tuesday | Feb 24, 2026

Cardinal Health report highlights cost savings and provider confidence in biosimilars

PRNewsWire

New analysis shows biosimilars are projected to strengthen cost savings and provider confidence across the healthcare ecosystem, with oncology leading in adoption and accessibility gains. DUBLIN, Ohio, Feb. 24, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today released its 2026 Biosimilars Report: Driving access and patient outcomes in physician practices, which highlights the substantial savings biosimilars have delivered to the U.S. healthcare system and the strong confidence providers have in these treatments.

Read full article arrow
News Thumbnail